摘要
目的:观察消炎汤治疗盆腔炎性疾病的临床疗效。方法:选取2012年1月—2013年12月本院收治的盆腔炎性疾病伴炎性包块的女性患者72例,随机分为观察组及对照组各36例。对照组患者给予莫西沙星片治疗,观察组患者给予消炎汤治疗,观察两组患者的临床疗效、治疗前后盆腔炎性包块体积大小以及T细胞亚群、CRP值等炎症介质变化情况。结果:观察组治愈率为88.89%,对照组治愈率为72.22%,观察组治愈率明显高于对照组(P<0.05);观察组患者的盆腔内炎性包块体积大小明显小于对照组(P<0.05);两组患者的CD4+百分比、CD8+百分比、CD4+/CD8+比值、C-RP值等炎症介质指标具有差异性(P<0.05)。结论:消炎汤治疗盆腔炎性疾病伴炎性包块的患者可以缩小盆腔内炎性包块的体积,改善患者血清中炎症介质的水平,效果显著。
Objective： To observe the clinical effects of Anti-Inflammatory Decoction on pelvic inflammatory disease. Methods： 72 female patients received by this hospital from January,2012 to December,2013 diagnosed with pelvic inflammatory disease combined with inflammatory mass were randomized into observation group and control group,with 36 cases in each group. Control group were given Moxifloxacin Tablets and observation group were given Anti-Inflammatory Decoction. The clinical effects of both groups were observed. The the sizes of inflammatory mass and T cell subset,CRP values were observed and compared before and after the treatment. Results： The cure rate（ 88. 89%） in observation group was much higer than that in control group（ 72. 22%）（ P 〈0. 05）. The size of the inflammatory mass in observation group was much smaller than that in control group（ P 〈0. 05）.There was difference in the percentage of CD4 ＋ and CD8 ＋,the ratio of CD4 ＋ / CD8 ＋,C-RP value of the two groups（ P 〈0. 05）. Conclusion： In treatment pelvic inflammatory disease combined with inflammatory mass,Anti-Inflammatory Decoction can reduce the size of the inflammatory mass,improve the levels of inflammatory mediator in the serum,which is of remarkable effects.
出处
《河南中医》
2015年第6期1360-1362,共3页
Henan Traditional Chinese Medicine
关键词
盆腔炎性疾病
炎性包块
炎症介质
消炎汤
pelvic inflammatory disease
inflammatory mass
inflammatory mediator
Anti-Inflammatory Decoction
